Cree Inc. [NASDAQ: CREE] gained 11.55% on the last trading session, reaching $81.00 price per share at the time. The company report on November 2, 2020 that Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors.
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced the appointment of Anne Whitaker to its Board of Directors. Ms. Whitaker is a seasoned healthcare executive bringing to Caladrius 28 years of experience in the life science industry, including senior leadership roles with large pharmaceutical, biotech and specialty pharma companies, and with a proven track record of building and leading high performance teams to successfully commercialize pharmaceuticals, consumer products and medical devices.
“It is with great pleasure that we welcome Anne Whitaker to the Board of Directors,” said Gregory B. Brown, MD, Caladrius’ Board Chairman. “Anne brings a wealth of experience to Caladrius gained over a distinguished career in executive roles in the life sciences industry. Her knowledge and experience in business strategy, business development, regulatory affairs, leadership and organizational development and commercialization will be invaluable to the Company as we continue to advance Caladrius’ clinical programs through late-stage development and commercialization.”.
Cree Inc. represents 109.71 million in outstanding shares, while the company has a total market value of $8.79 billion with the latest information. CREE stock price has been found in the range of $74.18 to $81.01.
If compared to the average trading volume of 1.13M shares, CREE reached a trading volume of 3318303 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cree Inc. [CREE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CREE shares is $68.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CREE stock is a recommendation set at 2.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Cree Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 19, 2020. The new note on the price target was released on August 19, 2020, representing the official price target for Cree Inc. stock.
The Average True Range (ATR) for Cree Inc. is set at 3.44, with the Price to Sales ratio for CREE stock in the period of the last 12 months amounting to 10.01. The Price to Book ratio for the last quarter was 4.66, with the Price to Cash per share for the same quarter was set at 10.49.
Trading performance analysis for CREE stock
Cree Inc. [CREE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.82. With this latest performance, CREE shares gained by 13.18% in over the last four-week period, additionally plugging by 56.58% over the last 6 months – not to mention a rise of 83.72% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CREE stock in for the last two-week period is set at 72.62, with the RSI for the last a single of trading hit 77.53, and the three-weeks RSI is set at 66.59 for Cree Inc. [CREE]. The present Moving Average for the last 50 days of trading for this stock 66.93, while it was recorded at 73.29 for the last single week of trading, and 56.02 for the last 200 days.
Cree Inc. [CREE]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Cree Inc. [CREE] shares currently have an operating margin of -18.13 and a Gross Margin at +25.87. Cree Inc.’s Net Margin is presently recorded at -21.21.
Return on Total Capital for CREE is now -6.06, given the latest momentum, and Return on Invested Capital for the company is -7.11. Return on Equity for this stock declined to -9.31, with Return on Assets sitting at -6.34. When it comes to the capital structure of this company, Cree Inc. [CREE] has a Total Debt to Total Equity ratio set at 39.01. Additionally, CREE Total Debt to Total Capital is recorded at 28.06, with Total Debt to Total Assets ending up at 25.15. Long-Term Debt to Equity for the company is recorded at 38.59, with the Long-Term Debt to Total Capital now at 27.76.
Reflecting on the efficiency of the workforce at the company, Cree Inc. [CREE] managed to generate an average of -$37,368 per employee. Receivables Turnover for the company is 7.24 with a Total Asset Turnover recorded at a value of 0.30.Cree Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.80 and a Current Ratio set at 4.30.
Cree Inc. [CREE]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Cree Inc. posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -11.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CREE.
An analysis of insider ownership at Cree Inc. [CREE]
There are presently around $9,479 million, in the hands of institutional investors. The top three institutional holders of CREE stocks are: CAPITAL RESEARCH GLOBAL INVESTORS with ownership of 13,435,964, which is approximately 2.524% of the company’s market cap and around 0.80% of the total institutional ownership; BLACKROCK INC., holding 13,026,096 shares of the stock with an approximate value of $1.06 billion in CREE stocks shares; and VANGUARD GROUP INC, currently with $802.21 million in CREE stock with ownership of nearly -2.85% of the company’s market capitalization.
Positions in Cree Inc. stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 141 institutional holders increased their position in Cree Inc. [NASDAQ:CREE] by around 9,328,985 shares. Additionally, 164 investors decreased positions by around 5,789,504 shares, while 61 investors held positions by with 101,905,246 shares. The mentioned changes placed institutional holdings at 117,023,735 shares, according to the latest SEC report filing. CREE stock had 48 new institutional investments in for a total of 1,494,263 shares, while 36 institutional investors sold positions of 135,785 shares during the same period.